SPPI News and Press, Spectrum Pharmaceuticals Inc. From 12/26/19

Gainers:  China Rapid Finance (NYSE: XRF ) +142% . More news on: China Rapid Finance Limited, Liquidia Technologies, Inc., NewLink Genetics Corporation, Stocks on the move, Read more ...

The stock market picked up some ground on Thursday morning, as investors looked to see whether the traditional Santa Claus rally would assert itself between now and the end of the year. Forecasts for 2020 are all over the board, but for now, market participants seem content to enjoy the big gain...

Spectrum Pharmaceuticals (NASDAQ: SPPI )  -54%  after poziotinib misses endpoing. More news on: Spectrum Pharmaceuticals, Inc., Spring Bank Pharmaceuticals, Inc., QIAGEN N.V., Stocks on the move, Read more ...

Spectrum Pharmaceuticals (NASDAQ: SPPI )  reports that its Phase 2 clinical trial evaluating poziotinib in previously treated non-small cell lung cancer didn't meet its primary endpoint for objective response rate. More news on: Spectrum Pharmaceuticals, Inc., Healthcare stocks news,...

Spectrum Pharmaceuticals, Inc. (NASDAQ-GS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today reported that its pre-specified primary endpoint in its Phase 2 clinical trial evaluating poziotinib in previously treated non-small cell lung cancer (NSCLC) p...

Merck's $2.7B bid for ArQule is yet another example of the Big Biopharma's high regard for oral kinase inhibitors for treating cancer. ArQule's lead drug is ARQ 531, an oral inhibitor of Bruton's tyrosine kinase (BTK). More news on: Pfizer Inc., Eli Lilly and Company, AbbVie Inc., Health...

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, announced today that an overview of the company's business strategy and development-stage programs will be given at the Jefferies 2019 London Healthcare Conference being he...

Spectrum Pharmaceuticals, Inc. (SPPI) Q3 2019 Earnings Conference Call November 7, 2019 4:30 PM ET Company Participants Shiv Kapoor - Vice President, Strategic Planning & Investor Relations Joseph Turgeon - Chief Executive Officer Kurt Gustafson - Chief Financial Officer Fr...

Image source: The Motley Fool. Spectrum Pharmaceuticals Inc   (NASDAQ: SPPI) Q3 2019 Earnings Call Nov 7, 2019 , 4:30 p.m. ET Operator Continue reading

Spectrum Pharmaceuticals (NASDAQ: SPPI ): Q3 Non-GAAP EPS of -$0.22; GAAP EPS of -$0.24 beats by $0.17 . Cash & equivalents of $252M. Press Release More news on: Spectrum Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news,